Ναμίμπια - Αγγλικά - Namibia Medicines Regulatory Council

aventis pharma (pty) limited - nadroparin calcium - injection - each 0,3 ml of solution contains nadroparin calcium 2850 iu axa

Ναμίμπια - Αγγλικά - Namibia Medicines Regulatory Council

pharmacare limited - nadroparin calcium - injection - each 0,2 ml of solution contains nadroparin calcium 1900 iu axa

Ναμίμπια - Αγγλικά - Namibia Medicines Regulatory Council

pharmacare limited - nadroparin calcium - injection - each 0,4 ml of solution contains nadroparin calcium 3800 iu axa

Ναμίμπια - Αγγλικά - Namibia Medicines Regulatory Council

pharmacare limited - nadroparin calcium - injection - each 0,6 ml of solution contains nadroparin calcium 5700 iu axa

Ναμίμπια - Αγγλικά - Namibia Medicines Regulatory Council

pharmacare limited - nadroparin calcium - injection - each 0,8 ml of solution contains nadroparin calcium 7600 iu axa

Μπανγκλαντές - Αγγλικά - DGDA (Directorate General of Drug Administration)

jenphar bangladesh ltd. - naproxen - tablet - 250 mg

Μπανγκλαντές - Αγγλικά - DGDA (Directorate General of Drug Administration)

jenphar bangladesh ltd. - naproxen - tablet - 500 mg

Ισραήλ - Αγγλικά - Ministry of Health

glaxo smith kline (israel) ltd - nadroparin calcium 3800 iu / 0.4 ml - solution for injection - nadroparin - prophylactic treatment of venous thromboembolic disease during surgery for patients presenting with moderate or high risk. treatment of constituted deep vein thrombosis. prevention of coagulation in the extra corporeal circuit during heamodialysis. the prophylaxis of thromboembolic disorders in high risk medical patients (respiratory failure and/or respiratory infection and/or cardiac failure) hospitalised in intensive care unit.

Ισραήλ - Αγγλικά - Ministry of Health

glaxo smith kline (israel) ltd - nadroparin calcium 2850 iu / 0.3 ml - solution for injection - nadroparin - prophylactic treatment of venous thromboembolic disease during surgery for patients presenting with moderate or high risk. treatment of constituted deep vein thrombosis. prevention of coagulation in the extra corporeal circuit during haemodialysis. the prophylaxis of thromboembolic disorders in high risk medical patients (respiratory failure and/or respiratory infection and/or cardiac failure) hospitalised in intensive care unit.

Ισραήλ - Αγγλικά - Ministry of Health

glaxo smith kline (israel) ltd - nadroparin calcium 5700 iu / 0.6 ml - solution for injection - nadroparin - prophylactic treatment of venous thromboembolic disease during surgery for patients presenting with moderate or high risk. treatment of constituted deep vein thrombosis. prevention of coagulation in the extra corporeal circuit during haemodialysis. the prophylaxis of thromboembolic disorders in high risk medical patients (respiratory failure and/or respiratory infection and/or cardiac failure) hospitalised in intensive care unit.